Leisl Packer - Concepedia

Author

Leisl Packer

QIMR Berghofer Medical Research Institute

Also Known As

, L Packer, L. Packer, Leisl M Packer, Leisl M. Packer, Leisl Packer, Leisl M. Packer, Packer, Leisl M.

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute Institute of Cancer Research Mater Research Leiden University Medical Center Cancer Research UK

About

Leisl Packer is an author at QIMR Berghofer Medical Research Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Cell Biology	9	9	1K
3	Public Health	1	1	13
4	Epidemiology	1	1	13
5	Metabolism	1	1	71

Leisl Packer

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas, Cancer Research Cell SubsetsTumor BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2010	261
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS Wieke Zuidervaart, Frans van Nieuwpoort, Mitchell Stark, British Journal of Cancer	2005	214
Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A Imanol Arozarena, Berta Sanchez‐Laorden, Leisl Packer, Cancer Cell Signal TransductionCell RegulationReceptor Tyrosine KinaseMelanomaCgmp-specific Phosphodiesterase Pde5a	2011	208
Microarray expression profiling in melanoma reveals a BRAF mutation signature Sandra Pavey, Peter A. Johansson, Leisl Packer, Oncogene Microarray ExpressionFunctional GenomicsMedicineGeneticsMelanoma	2004	182
Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia Leisl Packer, Sareena Rana, Robert Hayward, Cancer Cell Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2011	123
Activation of Forkhead Box O Transcription Factors by Oncogenic BRAF Promotes p21cip1-Dependent Senescence Peter L.J. de Keizer, Leisl Packer, Anna A. Szypowska, Cancer Research Oncogene-induced SenescenceSystems BiologySignaling PathwayCell RegulationGenetics	2010	91
Oxidative stress and mitochondrial dysfunction in neurodegeneration. Tritschler Hj, Leisl Packer, R. Medori PubMed Neurodegenerative DiseasesMitophagyMitochondrial DiseaseMitochondrial FunctionMitochondrial Dysfunction	1994	71
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN Leisl Packer Carcinogenesis	2006	63
Identification of direct transcriptional targets of <sup>V600E</sup>BRAF/MEK signalling in melanoma Leisl Packer, Philip East, Jorge S. Reis‐Filho, Pigment Cell & Melanoma Research Other BrafTranscriptional RegulationSystems BiologySignal TransductionCell Regulation	2009	61
Expression of the cell surface mucin gene family in adenocarcinomas. Leisl Packer, Stephanie J. Williams, Shirley Callaghan, International Journal of Oncology Complex GlycoproteinsOncologyGastrointestinal OncologyApical Membrane SurfaceMedicine	2004	59

Page 1